Cancer Occurrence During Follow-Up of the CAPP2 Study: Aspirin Use For Up To Four Years Significantly Reduces Lynch Syndrome Cancers for up to Several Years After Completion of Therapy

Burn, J; Mathers, JC; Gerdes, AM; Bisgaard, ML; Evans, G; Eccles, D; Lindblom, A; Macrae, F; Maher, ER; Mecklin, JP; Moslein, G; Olschwang, S; Ramesar, R; Vasen, HFA; Wijnen, J; Barker, G; Elliott, F; Lynch, H; Bishop, DT; CAPP2, Consortium

Cancer Occurrence During Follow-Up of the CAPP2 Study: Aspirin Use For Up To Four Years Significantly Reduces Lynch Syndrome Cancers for up to Several Years After Completion of Therapy

Lookup NU author(s): Professor Sir John Burn ORCiD, Professor John Mathers, Dr Anne-Marie Gerdes

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Burn J, Mathers JC, Gerdes AM, Bisgaard ML, Evans G, Eccles D, Lindblom A, Macrae F, Maher ER, Mecklin JP, Moslein G, Olschwang S, Ramesar R, Vasen HFA, Wijnen J, Barker G, Elliott F, Lynch H, Bishop DT, CAPP2 Consortium

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Annals of Oncology: European Multidisciplinary Colorectal Cancer Congress

Year of Conference: 2010

Pages: I16

ISSN: 0923-7534

Publisher: Oxford University Press

Library holdings: Search Newcastle University Library for this item

ISBN: 15698041

ePrints

Cancer Occurrence During Follow-Up of the CAPP2 Study: Aspirin Use For Up To Four Years Significantly Reduces Lynch Syndrome Cancers for up to Several Years After Completion of Therapy

Downloads

Publication metadata

Share